VRTX vs. ABBV
Compare and contrast key facts about Vertex Pharmaceuticals Incorporated (VRTX) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VRTX or ABBV.
Correlation
The correlation between VRTX and ABBV is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VRTX vs. ABBV - Performance Comparison
Key characteristics
VRTX:
-0.11
ABBV:
0.41
VRTX:
0.02
ABBV:
0.66
VRTX:
1.00
ABBV:
1.10
VRTX:
-0.12
ABBV:
0.51
VRTX:
-0.32
ABBV:
1.26
VRTX:
8.56%
ABBV:
7.72%
VRTX:
24.76%
ABBV:
23.80%
VRTX:
-91.77%
ABBV:
-45.09%
VRTX:
-18.33%
ABBV:
-15.05%
Fundamentals
VRTX:
$108.68B
ABBV:
$303.17B
VRTX:
-$1.94
ABBV:
$2.87
VRTX:
1.10
ABBV:
0.41
VRTX:
$8.09B
ABBV:
$41.23B
VRTX:
$6.99B
ABBV:
$30.76B
VRTX:
-$699.50M
ABBV:
$17.62B
Returns By Period
In the year-to-date period, VRTX achieves a 4.79% return, which is significantly higher than ABBV's -2.54% return. Over the past 10 years, VRTX has underperformed ABBV with an annualized return of 12.99%, while ABBV has yielded a comparatively higher 15.32% annualized return.
VRTX
4.79%
-5.70%
-14.15%
-2.54%
12.37%
12.99%
ABBV
-2.54%
0.97%
1.31%
7.92%
19.25%
15.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VRTX vs. ABBV — Risk-Adjusted Performance Rank
VRTX
ABBV
VRTX vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VRTX vs. ABBV - Dividend Comparison
VRTX has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.67%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.67% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
VRTX vs. ABBV - Drawdown Comparison
The maximum VRTX drawdown since its inception was -91.77%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for VRTX and ABBV. For additional features, visit the drawdowns tool.
Volatility
VRTX vs. ABBV - Volatility Comparison
Vertex Pharmaceuticals Incorporated (VRTX) has a higher volatility of 14.28% compared to AbbVie Inc. (ABBV) at 5.76%. This indicates that VRTX's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VRTX vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities